Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 209.54B, Merck(MRK) trades at $83.86. The stock has a price-to-earnings ratio of 10.91 and currently yields dividends of 3.9%.
As of 2025-11-05, Merck(MRK) stock has fluctuated between $82.00 and $84.96. The current price stands at $83.86, placing the stock +2.3% above today's low and -1.3% off the high.
The Merck(MRK)'s current trading volume is 12.85M, compared to an average daily volume of 10.88M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
MRK News
Merck recently announced an agreement to receive US$700 million in funding from Blackstone Life Sciences to advance the development of sacituzumab tirumotecan,...
New insider activity at Merck & Company ( (MRK) ) has taken place on November 4, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at...
Investors were unimpressed with Merck's Q3 financial results. The stock for pharmaceutical giant Merck (MRK +1.28%) was trading down more than 3% Monday mornin...
Analyst ratings
55%
of 29 ratingsMore MRK News
Merck (MRK) on Tuesday announced an agreement under which funds managed by Blackstone (BX) Life Sciences will provide the New Jersey-based pharma giant with $70...
(RTTNews) - Merck & Co Inc. (MRK) on Tuesday announced that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for the develo...
Merck (MRK) announced that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences for the development of sacituzumab tir...
Merck (MRK) announced that the company, through a subsidiary, Prometheus BioSciences, has reached an agreement with Dr. Falk Pharma GmbH to discontinue an exist...
With yields of up to 7%, this trio of high-yield stocks are all industry-leading companies. If you are looking for high-yield stocks today, you might want to f...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Merck (MRK) to $100 from $98 and keeps an Equal Weight rating on the shares. Q3 results b...
Merck & Company ((MRK)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks...